Skip Ribbon Commands
Skip to main content
Menu
Dr Fam Jiang Ming from National Heart Centre Singapore

Adj Asst Prof Fam Jiang Ming

MBBS (Singapore), MRCP (UK),
M Med (Int Med), FAMS, Ph.D.

Consultant

National Heart Centre Singapore

Specialty: Cardiology

Sub-specialties: Interventional Cardiology

Clinical Appointments

  • Consultant Department of Cardiology National Heart Centre SingaporeNational Heart Centre Singapore
  • Consultant NHCS Cardiology @ SKH Sengkang General HospitalSengkang General Hospital

Profile

Adj Asst Prof Fam Jiang Ming is a Consultant with the Department of Cardiology at the National Heart Centre Singapore. His subspecialty interest is in interventional cardiology. 

He has participated in interventional conferences such as ASIA-PCR and NHCS CTO Live as a live case operator since 2014. Adj Asst Prof Fam completed his advanced specialist training in the field of cardiology, following which, he completed his advanced subspecialty training in interventional cardiology in Thorax centre, Erasmus Medical Centre, Rotterdam, the Netherlands.

Adj Asst Prof Fam is actively involved in education and research. He is a lecturer in the Singapore Polytechnic Diploma in Cardiac Technology Course and is part of the faculty of DUKE-NUS medical school and the SingHealth residency program. His research interests include intravascular physiology and imaging, as well as clinical outcomes in patients with percutaneous coronary intervention. He has presented his research findings in local and international conferences and is first/co-author of numerous research papers in local and international peer reviewed journals.

He is actively involved in research collaboration with Erasmus Medical Centre on interventional cardiology with an aim towards achieving a final research thesis. In addition, Adj Asst Prof Fam has special interests in the subjects of anticoagulation and point-of-care testing devices and on hospital committees, which look at the policies and practices, with regards to the use of anticoagulation and point-of-care testing devices.

Education

  • Ph.D., Erasmus University Rotterdam, 2018
  • FAMS, Specialist Accreditation Board Exam 2013
  • MRCP (UK); MMED (Internal Medicine), National University of Singapore 2009
  • Bachelor of Medicine and Surgery, National University of Singapore 2002

Professional Appointments and Committee Memberships

  • Consultant, Department of Cardiology, National Heart Centre Singapore
  • Adjunct Assistant Professor. Duke-NUS Medical School
  • Faculty Member and Examiner of Yoong Loo Lin School of Medicine Faculty Member from 2013
  • Faculty member with Duke-NUS Medical School from 2013

Awards

  • Quality Assurance (Gold) from SingHealth 2016
  • Best Poster Abstract - "Clinical outcome in patients with dual therapy stent" at the Transcatheter Cardiovascular Therapeutics AsiaPacific (TCTAP) Seoul, Korea 2014
  • Long Service Award from SingHealth 2014
  • Quality Assurance (Silver) from SingHealth 2014

Publications and Research Trials

  • Increased incidence of scaffold thrombosis in patients treated with Absorb BVS who terminated DAPT before 18 months. C.M. Felix; G. J. Vlachojannis; A.J.J. IJsselmuiden; J.M. Fam,; P.C. Smits; W. Lansink; R. Diletti; F. Zijlstra; E.S. Regar; Eric Boersma; Y. Onuma; R.J.M van Geuns.  EuroIntervention 2017 May 18. pii:EIJ –D-17-00119. doi:10.4244/EIJ–D-17-00119. [Epub ahead of print]
  • Reply: Meta-Analysis of the Index of Microvascular Resistance in Acute STEMI Using Incomplete data. JACC Cardiovasc Interv. Bulluck H, Foin N, Carbrera-Fuentes HA, Yeo KK, Wong AS, Fam JM, Wong PE, Tan JW, Low AF, Hausenloy DJ. 2017 Feb 27;10(4):422. doi: 10.1016/j.jcin.2017.01.003. 
  • Everolimus Eluting Bioresorbable Vascular Scaffold for Treatment of Complex Chronic Total Occlusions. Fam JM, Marcella De Paolis, Roberto Garbo, Alfredo R. Galassi, Nicolas M. van Mieghem MD, Jors van der Sijde, Cordula Felix, Giacomo Giovanni Boccuzzi, Boukhris Marouane, Gennaro Sardella, Felix Zijlstra, Robert Jan van Geuns, Roberto Diletti. EuroIntervention. 2017 Feb 21. pii: EIJ-D-16-00253. doi: 10.4244/EIJ-D-16-00253. [Epub ahead of print]
  • Defining Optimal Stent Overexpansion Strategies for Left Main Stenting- Insights from bench testing. Jiang Ming Fam, Peter Mortier, Matthieu De Beule, Tim Dezutter, Nicolas van Mieghem, Roberto Diletti, Bert Everaert , Soo Teik Lim, Felix Zijlstra, Robert-Jan van Geuns. AsiaIntervention [In press]
  • Expanded clinical use of everolimus eluting bioresorbable vascular scaffolds for treatment of coronary artery disease. Diletti R, Ishibashi Y, Felix C, Onuma Y, Nakatani S, van Mieghem NM, Regar E, Valgimigli M, de Jaegere PP, van Ditzhuijzen N, Fam JM, Ligthart JM, Lenzen MJ, Serruys PW, Zijlstra F, Jan van Geuns R. Catheter Cardiovasc Interv. 2016 Nov 29. doi: 10.1002/ccd.26832. [Epub ahead of print]
  • Resistance and Microvascular Obstruction in Patients With Acute Myocardial Infarction. JACC Cardiovasc Interv. Bulluck H, Foin N, Carbrera-Fuentes HA, Yeo KK, Wong AS, Fam JM, Wong PE, Tan JW, Low AF, Hausenloy DJ. Index of Microvascular 2016 Oct 24;9(20):2172-2174. doi: 10.1016/j.jcin.2016.08.018.
  • Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study. Ming Fam J, van Der Sijde JN, Karanasos A, Felix C, Diletti R, van Mieghem N, de Jaegere P, Zijlstra F, Jan van Geuns R, Regar E. Catheter Cardiovasc Interv. 2016 Oct 7. doi: 10.1002/ccd.26676. [Epub ahead of print]
  • Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry. Felix CM, Fam JM, Diletti R, Ishibashi Y, Karanasos A, Everaert BR, van Mieghem NM, Daemen J, de Jaegere PP, Zijlstra F, Regar ES, Onuma Y, van Geuns RJ. JACC Cardiovasc Interv. 2016 Aug 22;9(16):1652-63. doi: 10.1016/j.jcin.2016.04.035.
  • Optimization of coronary optical coherence tomography imaging using the attenuation-compensated technique: a validation study. Teo JC, Foin N, Otsuka F, Bulluck H, Fam JM, Wong P, Low FH, Leo HL, Mari JM, Joner M, Girard MJ, Virmani R. Eur Heart J Cardiovasc Imaging. 2016 Jul 28. pii: jew153. [Epub ahead of print]
  • Everolimus-eluting bioresorbable vascular scaffolds implanted in coronary bifurcation lesions: Impact of polymeric wide struts on side-branch impairment. De Paolis M, Felix C, van Ditzhuijzen N, Fam JM, Karanasos A, de Boer S, van Mieghem NM, Daemen J, Costa F, Bergoli LC, Ligthart JM, Regar E, de Jaegere PP, Zijlstra F, van Geuns RJ, Diletti R. Int J Cardiol. 2016 Oct 15;221:656-64. doi: 10.1016/j.ijcard.2016.06.153.
  • Over-expansion capacity and stent design model: An update with contemporary DES platforms. Ng J, Foin N, Ang HY, Fam JM, Sen S, Nijjer S, Petraco R, Di Mario C, Davies J, Wong P.Int J Cardiol. 2016 Oct 15;221:171-9. doi: 10.1016/j.ijcard.2016.06.097.
  • Differential thrombotic prolapse burden in either bioresorbable vascular scaffolds or metallic stents implanted during acute myocardial infarction: The snowshoe effect: Insights from the maximal footprint analysis. Diletti R, van der Sijde J, Karanasos A, Fam JM, Felix C, van Mieghem NM, Regar E, Rapoza R, Zijlstra F, van Geuns RJ. Int J Cardiol. 2016 Oct 1;220:802-8. doi: 10.1016/j.ijcard.2016.06.077.
  • Are BVS suitable for ACS patients? Support from a large single center real live registry. Felix CM, Onuma Y, Fam JM, Diletti R, Ishibashi Y, Karanasos A, Everaert BR, van Mieghem NM, Daemen J, de Jaegere PP, Zijlstra F, Regar ES, van Geuns RJ. Int J Cardiol. 2016 Sep 1;218:89-97. doi: 10.1016/j.ijcard.2016.05.037.
  • Simplified Models of Non-Invasive Fractional Flow Reserve Based on CT Images. Zhang JM, Zhong L, Luo T, Lomarda AM, Huo Y, Yap J, Lim ST, Tan RS, Wong AS, Tan JW, Yeo KK, Fam JM, Keng FY, Wan M, Su B, Zhao X, Allen JC, Kassab GS, Chua TS, Tan SY. PLoS One. 2016 May 17;11(5):e0153070. doi: 10.1371/journal.pone.0153070.
  • Impact of aortic root size on left ventricular afterload and stroke volume. Sahlén A, Hamid N, Amanullah MR, Fam JM, Yeo KK, Lau YH, Lam CS, Ding ZP. Eur J Appl Physiol. 2016 Jul;116(7):1355-65. doi: 10.1007/s00421-016-3392-0.
  • Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study. Fam JM, Felix C, van Geuns RJ, Onuma Y, Van Mieghem NM, Karanasos A, van der Sijde J, De Paolis M, Regar E, Valgimigli M, Daemen J, de Jaegere P, Zijlstra F, Diletti R. EuroIntervention. 2016 May 17;12(1):30-7. doi: 10.4244/EIJV12I1A6.
  • Safety of optical coherence tomography in daily practice: a comparison with intravascular ultrasound. van der Sijde JN, Karanasos A, van Ditzhuijzen NS, Okamura T, van Geuns RJ, Valgimigli M, Ligthart JM, Witberg KT, Wemelsfelder S, Fam JM, Zhang B, Diletti R, de Jaegere PP, van Mieghem NM, van Soest G, Zijlstra F, van Domburg RT, Regar E. Eur Heart J Cardiovasc Imaging. 2016 Mar 18. pii: jew037. [Epub ahead of print]
  • An Unusual Case of Stent-in-Stent Thrombosis. Fam JM, den Dekker W, de Graaf P, Regar E. JACC Cardiovasc Interv. 2015 Dec 28;8(15):e261-2. doi: 10.1016/j.jcin.2015.07.039. No abstract available. 
  • Critical analysis of the correlation between optical coherence tomography versus intravascular ultrasound and fractional flow reserve in the management of intermediate coronary artery lesion. Ma YF, Fam JM, Zhang BC. Int J Clin Exp Med. 2015 May 15;8(5):6658-67. Review.
  • Clinical and angiographic outcomes of rotational atherectomy for patients with calcified coronary lesions: a meta-analysis of randomized and observational studies. Bu-Chun Zhang, Jiang-Ming Fam, Cheng Wang. Int J Clin Exp Med 2016;9(2). Review.
  • Use of intracoronary imaging in ST Elevation Myocardial Infarction with coronary artery aneurysm and very late stent thrombosis. Fam JM, van der Sijde JN, Karanasos A, Zhang B, van Geuns RJ, Regar E. Int J Cardiol. 2015 Oct 15;197:296-9. doi: 10.1016/j.ijcard.2015.05.087. 
  • Bioresorbable vascular scaffold for ST elevation myocardial infarction: optical coherence tomography observations at the 2-year follow-up. Fam JM, Karanasos A, Regar E, van Geuns RJ. Coron Artery Dis. 2015 Sep;26(6):545-7. doi: 10.1097/MCA.0000000000000256. 
  • The rapid identification of Clostridium perfringens as the possible aetiology of a diarrhoeal outbreak using PCR. Loh JP, Liu YC, Chew SW, Ong ES, Fam JM, Ng YY, Taylor MB, Ooi EE. Epidemiol Infect. 2008 Aug;136 (8):1142-6.
  • Implantation technique for Bioresorbable Scaffolds. Jiang Ming Fam; Robert-Jan van Geuns. Cardiac Interventions Today January 2017
  • Review on noninvasive risk stratification of Sudden Cardiac Death. Fam JM, Ching CK et al.  Singhealth Proceedings. 2011;20(4)
  • Optical Coherence Tomography in grafts. MN AL-Qezweny, JN van der Sijde, Jiang Ming Fam, A Karanasos, BC Zhang, E Regar. [Book Chapter]
  • A descriptive prevalence study on patients with reduced ejection fraction in Singapore. Fam JM, Lay Wai Khin, David Kheng Leng Sim, Kah Leng Ho, Reginald Liew, Wee Siong Teo, Chi Keong Ching. Asian Congress of Heart Failure October 2010, Busan Korea.
  • Predictors of 2-year mortality rate and cumulative MACE in Asian patients with ejection fraction £ 40%. Fam JM, Tan BY, Reginald Liew, Daniel Chong, Teo WS, David Sim, Ching CK. Asian Congress of Heart Failure October 2010 Busan, Korea.
  • Electrophysiological Characteristics of Patients who undergo Two or more ablations for Atrial Fibrillation. Fam JM, Tan BY, Reginald Liew, Daniel Chong, Teo WS, Ching CK. Asia Pacific Heart Rhythm Society October September 2011 Fukuoka, Japan.
  • Magnetic stereotaxis in complex congenital heart disease (CHD) and tachyarrthymias- a single centre experience. Fam JM, Tan BY, Reginald Liew, Daniel Chong, Ching CK, Teo WS. Singapore Cardiac Society Annual Scientific Meeting January 2012.
  • Effect of magnetic stereotaxis on procedure and fluoroscopy times in catheter based electrophysiological ablation of atrial flutter in atrial septal defects- a single centre experience. Fam JM, Tan BY, Reginald Liew, Daniel Chong, Ching CK, Teo WS.Asia Pacific Heart Rhythm Society October 2012 Taipei, Taiwan.
  • Remote Magnetic Navigation and ablation in patients with congenital heart disease (CHD) and tachyarrthymias. Fam JM, Tan BY, Reginald Liew, Daniel Chong, Ching CK, Teo WS. Asia Pacific Heart Rhythm Society October 2012 Taipei, Taiwan.
  • Clinical characteristics and 1-year readmission rates, length of stay, cost and mortality for men and women undergoing percutaneous coronary intervention. Fam JM, KK Yeo, YH Lau, James Cai, LL Sim, ST Lim, T SJ Chua, TH Koh. ASIA-PCR 2012, Singapore.
  • Comparison of clinical characteristics, 1-year readmission rates, cost and mortality amongst patients undergoing percutaneous coronary intervention for stable angina, acute coronary syndromes and ST-elevation myocardial infarction. KK Yeo, Fam JM, YH Lau, James Cai, LL Sim, ST Lim, T SJ Chua, TH Koh. ASIA-PCR 2012, Singapore.
  • Outcomes, outpatient costs and adherence to guideline guided therapy in SAP, ACS and STEMI patients undergoing percutaneous coronary intervention (PCI). Fam JM, KK Yeo, YH Lau, James Cai, LL Sim, ST Lim, T SJ Chua, TH Koh. European Society of Congress (ESC), Munich, Germany. Aug 2012.
  • Ethnicity, outcomes, outpatient costs and adherence to guideline guided therapy in patients undergoing percutaneous coronary intervention (PCI). James Cai, KK Yeo, Fam JM, YH Lau, , LL Sim, ST Lim, T SJ Chua, TH Koh. European Society of Congress (ESC), Munich, Germany. Aug 2012.
  • Outcomes, outpatient costs and adherence to guideline guided therapy in patients with left ventricular ejection fraction <=40% undergoing percutaneous coronary intervention (PCI). Fam JM, KK Yeo, YH Lau, James Cai, LL Sim, ST Lim, T SJ Chua, TH Koh. International Academy of Cardiology, 17th World Congress on Heart Disease, Annual Scientific Sessions,Toronto, ON, Canada. July 2012
  • Predictors of nonadherence to guideline recommended therapy and outcomes in patients undergoing PCI. Fam JM, KK Yeo, YH Lau, James Cai, LL Sim, ST Lim, T SJ Chua, TH Koh. International Academy of Cardiology, 17th World Congress on Heart Disease, Annual Scientific Sessions,Toronto, ON, Canada. July 2012
  • Impact of subsidy level on outcomes and adherence to guideline recommended therapy in patients undergoing PCI. Fam JM, KK Yeo, YH Lau, James Cai, LL Sim, ST Lim, T SJ Chua, TH Koh. Duke-NUS Scientific Congress, Singapore.  Aug 2012.
  • Ethnicity, outcomes, outpatient costs and adherence to guideline recommended therapy in patients undergoing percutaneous coronary intervention. James Cai, KK Yeo, Fam JM, YH Lau, , LL Sim, ST Lim, T SJ Chua, TH Koh. Duke-NUS Scientific Congress, Singapore.  Aug 2012.
  • Guideline recommended therapy and outcomes in patients undergoing PCI in Singapore. Fam JM, KK Yeo, YH Lau, James Cai, LL Sim, ST Lim, T SJ Chua, TH Koh. Asean Federation of Cardiology Congress, Singapore. 12-15 July 2012.
  • Outcomes and predictors of 1 year all-cause mortality in patients undergoing percutaneous coronary intervention (PCI). Fam JM, KK Yeo, YH Lau, James Cai, LL Sim, ST Lim, TH Koh, T SJ Chua. ASIA- PCR January 2013.
  • Racial differences in outcomes and predictors of 1 year all-cause mortality in patients undergoing percutaneous coronary intervention (PCI). Fam JM, KK Yeo, YH Lau, James Cai, LL Sim, ST Lim, TH Koh, T SJ Chua. ASIA- PCR January 2013
  • Gender differences in outcomes and predictors of 1 year all-cause mortality in patients undergoing percutaneous coronary intervention (PCI). Xinzhe James Cai, KK Yeo, JM Fam, YH, Lau, LL So,, ST Lim, TH Koh, T Chua SJ. ASIA- PCR January 2013
  • Angiographic characteristics of patients who underwent percutaneous coronary intervention- a single registry experience. Fam JM, KK Yeo, YH Lau, James Cai, LL Sim, ST Lim, TH Koh, T SJ Chua. SGH Annual Scientific Meeting April 2013
  • Clinical outcome in dialysis patients who underwent percutaneous coronary intervention. Jiang Ming Fam, Chun Yuan Khoo, Jonathan Yap, Khung Keong Yeo, Xinzhe James Cai, Yee How Lau, Ling Ling Sim, Soo Teik Lim, Terrance Siang Jin Chua, Tian Hai Koh. WCC Melbourne 2014
  • Angiographic Characteristics and Clinical outcomes of the use of Dual Therapy Stent. Jiang Ming Fam, Rena Lim Cai Zuan, Yee How Lau, Dr Kay Woon Ho, Dr Chee Tang Chin, Dr Paul Toon Lim Chiam, Dr Khung Keong Yeo, Dr Jack Wei Chieh Tan, Prof Soo Teik Lim, Prof Tian Hai Koh, Dr Aaron Sung Lung Wong. TCTAP 2014.
  • Prevalence of high DFT (Defibrillation Threshold) in Singapore. Jiang Ming Fam, Paul Lim, Lohendran Baskaran, Daniel Chong, Boon Yew Tan, Kah Leng Ho, Reginald Liew, Wee Siong Teo, Chi Keong Ching. Asia Pacific Heart Rhythm Society October 2012 Taipei ,Taiwan
  • Defibrillation threshold testing using a step up, one shock testing protocol commencing at 10J shock energy. Paul Lim, Jiang Ming Fam, Lohendran Baskaran, Daniel Chong, Boon Yew Tan, Kah Leng Ho, Reginald Liew, Wee Siong Teo, Chi Keong Ching. Asia Pacific Heart Rhythm Society October 2012 Taipei ,Taiwan
  • Defibrillation threshold testing using a step up, one shock testing protocol commencing at 10J shock energy in patients with low ejection fraction. Jiang Ming Fam, Paul Lim, Lohendran Baskaran, Daniel Chong, Boon Yew Tan, Kah Leng Ho, Reginald Liew, Wee Siong Teo, Chi Keong Ching. Asia Pacific Heart Rhythm Society October 2012 Taipei ,Taiwan.
  • Does lesion calcification affect expansion of bioresorbable scaffolds? - An optical coherence tomography study in calcified and non-calcified lesions. Jiang Ming Fam, Antonios Karanasos, Roberto Dilleti, Nicolas van Mighem, Marco Valgimigli,  Floris Kauer, Peter de Jaegere, Felix Zijlstra , Robert Jan van Geuns,  Evelyn Regar. ASIAPCR 2015.
  • Defining Optimal Stent Overexpansion Strategies for Left Main PCI- Insights from bench testing. Jiang Ming Fam, Peter Mortier, Matthieu De Beule, Tim Dezutter, Nicolas van Mieghem, Roberto Diletti, Bert Everaert , Soo Teik Lim, Felix Zijlstra, Robert-Jan van Geuns. CRT 2015
  • A Study Of Conformability in Everolimus-eluting Bioresorbable Vascular Scaffolds to Metal Platform Coronary Stents in Long Lesions. Jiang Ming Fam, Yuki Ishibashi, Cordula Felix, Bu Chun Zhang, Roberto Diletti, Nicolas van Mieghem, Evelyn Regar, Ron van Domburg, Yoshinobu Onuma, Robert- Jan van Geuns. CRT 2015.
  • Differences in stent/scaffold expansion between everolimus-eluting bioresorbable scaffolds and metallic drug-eluting stents in calcified lesions- An optical coherence tomography study. Jiang Ming Fam, Yuki Ishibashi, Cordula Felix, Bu Chun Zhang, Roberto Diletti, Nicolas van Mieghem, Evelyn Regar, Ron van Domburg, Yoshinobu Onuma, Robert- Jan van Geuns. EuroPCR 2015.
  • Incidence of persistent, resolved, and late incomplete scaffold apposition after bioresorbable scaffold implantation in ST-segment elevation myocardial infarction. Antonios Karanasos, Nicolas M. Van Mieghem, Hector Garcia-Garcia, Roberto Diletti, Cordula Felix, Jors N. van der Sijde, Jiang-Ming Fam, Yuki Ishibashi,Peter De Jaegere, Patrick W. Serruys, Yoshinobu Onuma, Felix Zijlstra, Evelyn Regar, Robert J. Van Geuns. A BVS-STEMI-first substudy. Poster. Oct 2015. TCT J Am Coll Cardiol. 2015;66(15_S):. doi:10.1016/j.jacc.2015.08.546 
  • Impact of postdilation on procedural and clinical outcomes in long and complex lesions treated with bioresorbable vascular scaffolds- a prospective registry study. Jiang-Ming Fam, Yoshinobu Onuma, Cordula Felix, Roberto Diletti, Nicolas M. Van Mieghem, Evelyn Regar, Peter De Jaegere, Felix Zijlstra, Robert J. Van Geuns . Poster TCT, Oct 2015. J Am Coll Cardiol. 2015;66(15_S):. doi:10.1016/j.jacc.2015.08.557 
  • Long-term Clinical Outcomes of Patients Treated With The Everolimus-eluting Bioresorbable Vascular Scaffold. Cordula Felix, Jiang-Ming Fam, Yoshinobu Onuma, Yuki Ishibashi, Bert Everaert, Roberto Diletti, Evelyn Regar, Nicolas M. Van Mieghem, Joost Daemen, Peter De Jaegere, Felix Zijlstra, Robert J. Van Geuns. The BVS Expand Study. Poster TCT • Oct 2015. J Am Coll Cardiol. 2015;66(15_S):. doi:10.1016/j.jacc.2015.08.544
  • Everolimus-eluting BRS implanted in coronary bifurcation lesions: impact of polymeric wide struts on side-branch impairment. De Paolis, Fam JM, Felix , Karanasos, Van mieghem N., Daemen, Costa, Bergoli, Ligthart J., De jaegere P., Regar , Zijlstra , Van geuns , Diletti R.. Oral Abstract. EuroPCR 2016
  • Everolimus-eluting BRS for treatment of complex CTO. Fam JM, De paolis, Garbo, Ojeda, Galassi A., Van Mieghem, Van der sijde, Cordula Felix, Pan, Boccuzzi, Marouane,  Mardella, Zijlstra, Van geuns, Diletti R. Oral Abstract. EuroPCR 2016
  • Everolimus-eluting BRS vs. metallic DES for treatment of patients presenting with acute myocardial infarction: insights from the maximal footprint analysis. Fam JM, Van der sijde, Karanosos, Van mieghem N., Onuma, Felix, De paolis, Regar, Valgimigli, Daemen, De jaegere, Rapoza , Zijlstra, Van geuns, Diletti R. Oral Abstract. EuroPCR 2016
  • Prediction of short-term mortality in ST-elevation myocardial infarction: the echocardiographic index E/e' is robust, powerful and specific. SB. Tai, WR. Lau, JM. Fam, N. Hamid, MR. Amanullah, YH. Lau, KK. Yeo, ZP. Ding, A. Sahlen. ESC 2016
  • Feasibility of direct scaffolding in acute coronary syndromes patients with relatively simple non-calcified culprit lesions. Tomaniak M, Felix C, Fam JM, van Geuns RJ, Van Mieghem Nicolas M, Regar E, Daemen J, de Jaegere P, Zijlstra F, Diletti R. A pooled analysis of BVS STEMI First and BVS Expand Studies. Poster Abstract. TCT 2016
  • Impact of scaffold oversizing, under-expansion and post-dilatation on acute angiographic and one year clinical outcomes in patients with ACS treated with bioresorbable vascular scaffolds. Tomaniak M, Fam JM, Felix C, van Geuns RJ, Van Mieghem Nicolas M, Regar E, Daemen J, de Jaegere P, Zijlstra F, Diletti R. Poster Abstract. TCT 2016.
  • Impact of optimal implantation technique on bioresorbable scaffold expansion and one-year clinical outcomes in patients presenting with acute coronary syndromes and calcified lesions. Tomaniak M, Felix C, Fam JM, van Geuns RJ, Van Mieghem Nicolas M, Regar E, Daemen J, de Jaegere P, Zijlstra F, Diletti R.   A pooled analysis of BVS STEMI First and BVS Expand Studies. Abstract TCT  2016.
  • Long-term clinical outcomes after implantation of  everolimus-eluting bioresorbable vascular scaffold in patients with acute myocardial infarction. Tomaniak M, Fam JM, Felix C, van Geuns RJ, Van Mieghem Nicolas M, Regar E, Daemen J,de Jaegere P, Zijlstra F, Diletti R. 24-month clinical follow-up of the BVS STEMI First Study. Abstract TCT 2016.
  • Impact of bioresorbable scaffold-specific implantation technique on device expansion in acute coronary syndromes. Tomaniak M, Fam JM, Felix C, Yoshinobu Ouma, van Geuns RJ, Joost Daemen, de Jaegere P, Van Mieghem Nicolas M, Zijlstra F, Diletti R. A pooled analysis from BVS STEMI First and BVS EXPAND studies. Abstract EuroPCR 2017.

Research Trials

  • Absorb IV
  • RevElution
  • Biosolve IV
  • FFRB
  • PARADISE-MI
  • PITRI
  • RevElution
  • GLOBAL LEADERS
  • POEMS
  • IMPROVE-IT: - a randomized, active-control, double-blind study of subjects with stabilized high-risk acute coronary syndrome
  • Biomarkers and Mx of CVM Disease - the "SHOP" study
  • RELY-ABLE study -LongTerm Multi-center Extension of Dabigatran Treatment in Patients With AF
  • ASTRONAUT: evaluate the 6 months efficacy and safety of aliskiren therapy in heart failure
  • Perindopril/Amlodipine versus Valsartan/Amlodipine txt: Efficacy and safety in hypertensive patients
  • EPICOR : A single centre registry to evaluate morbidity and mortality after ACS admission
  • LEADERS-FREE- A prospective randomized comparison of the BiofreedomR Biolimus A9TM Drug coated stent versus the GazelleR bare metal stent in patients at high risk of bleeding
  • Odyssey Outcomes Study- Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome
  • CapSureFix Novus Model 5076 Lead MRI Study
  • A Randomized, Multi-center, Placebo-controlled, Parallel-group Study to Determine the Effects of AMG 145 Treatment on Atherosclerotic Disease Burden as Measured by Intravascular Ultrasound in Subjects Undergoing Coronary Catheterization 
  • GLAGOV (GLobal Assessment of plaque reGression with a PCSK9 antibOdy as measured by intraVascular ultrasound)
  • GARFIELD- Prospective, multicentre, international registry of male and female patients newly diagnosed with atrial fibrillation